57 studies found for:    "Immune thrombocytopenia"
Show Display Options
Rank Status Study
1 Recruiting Low-dose Decitabine Versus Recombinant Human Thrombopoietin for the Treatment of Refractory Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Interventions: Drug: Decitabine;   Drug: rhTPO
2 Recruiting The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Intervention:
3 Not yet recruiting An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Intervention: Drug: Human immunoglobulin intravenous
4 Completed Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)
Conditions: Chronic Thrombocytopenia;   Immune Thrombocytopenia
Interventions: Drug: E5501 - Avatrombopag maleate;   Drug: E5501 - Avatrombopag maleate Matching Placebo
5 Terminated A Study to Investigate the Efficacy and Safety of S-888711 Tablets Administered to Adult Subjects With Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia (ITP)
Interventions: Drug: placebo to S-888711;   Drug: S-888711
6 Not yet recruiting Oxidant Status and Effect of Antioxidant in Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Interventions: Drug: Antox tablets(Mepaco);   Other: drug therapy for ITP
7 Completed Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia
Conditions: Immune Thrombocytopenia;   Systemic Lupus Erythematosus
Intervention:
8 Recruiting Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.
Conditions: Immune Thrombocytopenia;   Chemotherapy Induced Thrombocytopenia;   Myelodysplasia Related Thrombocytopenia;   Aplastic Anaemia Related Thrombocytopenia
Intervention: Other: Full blood count with extended platelet parameters
9 Completed Efficacy and Safety of Rituximab Given at Fixed Dose (1000 mg on Days 1 and 15) Compared to the Standard Regimen in Adult's Immune Thrombocytopenia
Condition: Primary Immune Thrombocytopenia
Intervention:
10 Recruiting Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001)
Condition: Immune Thrombocytopenia Purpura
Interventions: Drug: MK-8723;   Drug: Matching Placebo
11 Recruiting Alteration of Different Immune Parameters in Immune Thrombocytopenia (ITP) Patients Receiving Eltrombopag Treatment
Condition: Immune Thrombocytopenia
Intervention:
12 Recruiting Safety and Efficacy of Eltrombopag at Escalated Doses
Conditions: Immune Thrombocytopenia;   Platelet Disorder
Interventions: Drug: Eltrombopag;   Drug: Placebo
13 Completed An Open-label Safety Study of S-888711
Condition: Immune Thrombocytopenia
Intervention: Drug: 0.5 mg of S-888711
14 Recruiting ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP
Condition: Immune Thrombocytopenia
Intervention: Drug: Second Line ITP agents
15 Recruiting Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP
Conditions: Thrombocytopenia;   Immune Thrombocytopenia;   Idiopathic Thrombocytopenic Purpura
Intervention: Drug: rhTPO
16 Recruiting High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP
Condition: Immune Thrombocytopenia
Interventions: Drug: Dexamethasone;   Drug: Thalidomide
17 Unknown  The Role of Traditional Chinese Medicine in the Treatment of Chronic Childhood Immune Thrombocytopenia (ITP)
Condition: Childhood Chronic Immune Thrombocytopenia
Intervention: Drug: Bu Zhong Yi Qi Tang, Zhi Xue Tang, Chuan xin lian kang yan pian mod, Tian Wang Bu xin Dan
18 Recruiting Autoantibody Specificity and Response to IVIG in ITP
Condition: Immune Thrombocytopenia (ITP)
Intervention:
19 Completed Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety.
Conditions: Immune Thrombocytopenia;   Thrombopoietin Receptor Agonist
Intervention:
20 Recruiting Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics
Condition: Immune Thrombocytopenia Response to Thrombopoietin Mimetics
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years